Literature DB >> 29133141

Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis.

Yessica Garcia1, A Bernard Collins1, James R Stone2.   

Abstract

In the past, the diagnosis and typing of amyloidosis often required an invasive biopsy of an internal organ, such as the heart or kidneys. Abdominal fat pad excisional biopsy (FPEB) offers a less invasive approach, but the sensitivity of this technique has been unclear. To determine the sensitivity of FPEB for immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, we performed a retrospective clinicopathologic analysis of 97 patients who had undergone FPEB, of which 16 were positive for amyloid. The most significant pretest feature predicting a positive FPEB was a serum free light chain κ/λ ratio less than .5, and in this group of patients the probability of a positive biopsy was dependent on the size of the biopsy (P=.004). In FPEBs, the amyloid was present in multiple distinct patterns: pericellular, septal, medium-sized vessel, small vessel, and nodular. For patients with AL amyloidosis for which direct typing was attempted using the FPEB tissue, the amyloid was successfully typed in the FPEB in 90% of cases. The overall sensitivity of FPEB was 79% for AL amyloidosis and 12% for ATTR amyloidosis (P=.0003). In patients with AL amyloidosis, the sensitivity of FPEB was dependent on biopsy size, with small biopsies (≤700 mm3) having a sensitivity of ~50%, and large biopsies (>700 mm3) having a sensitivity of ~100%. This study demonstrates that FPEB has high sensitivity for AL amyloidosis, and can be routinely used to type the amyloid. However, FPEB has low sensitivity for ATTR amyloidosis in our patient population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AL amyloidosis; ATTR amyloidosis; Biopsy size; Diagnostic rest; Sensitivity; Serum-free light chain

Mesh:

Substances:

Year:  2017        PMID: 29133141     DOI: 10.1016/j.humpath.2017.11.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Authors:  Iuliana Vaxman; Angela Dispenzieri; Eli Muchtar; Morie Gertz
Journal:  Blood Rev       Date:  2019-11-02       Impact factor: 8.250

Review 2.  Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.

Authors:  A Hänselmann; D Berliner; J Bauersachs; U Bavendiek
Journal:  Herz       Date:  2022-06-08       Impact factor: 1.740

3.  Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Authors:  Panagiota Kyriakou; Dimitrios Mouselimis; Anastasios Tsarouchas; Angelos Rigopoulos; Constantinos Bakogiannis; Michel Noutsias; Vasileios Vassilikos
Journal:  BMC Cardiovasc Disord       Date:  2018-12-04       Impact factor: 2.298

4.  Approach to a patient with cardiac amyloidosis.

Authors:  Christopher Strouse; Alexandros Briasoulis; Rafael Fonseca; Yogesh Jethava
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327

Review 5.  Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach.

Authors:  Yi L Hwa; Teresa Fogaren; Allison Sams; Douglas V Faller; Dawn M Stull; Sara Thuenemann; Lisa Mendelson
Journal:  J Adv Pract Oncol       Date:  2019-07-01

Review 6.  Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis.

Authors:  Agnieszka Stelmach-Gołdyś; Monika Zaborek-Łyczba; Jakub Łyczba; Bartosz Garus; Marcin Pasiarski; Paulina Mertowska; Paulina Małkowska; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 7.  Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.

Authors:  Paul J Scheel; Monica Mukherjee; Allison G Hays; Joban Vaishnav
Journal:  Front Cardiovasc Med       Date:  2022-03-24

8.  Negative Fat Pad Biopsy in Systemic AL: A Case Report Analyzing the Preferred Amyloidosis Screening Test.

Authors:  Kelsey Hummel; Hany Meawad; William T Gunning; Amira F Gohara
Journal:  Diseases       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.